Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases.

Caminero, Jose A; Piubello, Alberto; Scardigli, Anna; Migliori, Giovanni Battista

Caminero, Jose A; Piubello, Alberto; Scardigli, Anna; Migliori, Giovanni Battista.

Affiliation

Caminero JA; Pneumology Department, Hospital General de Gran Canaria "Dr. Negrin", Las Palmas de GC, Spain jcamlun@gobiernodecanarias.org.
Piubello A; Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France.
Scardigli A; Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France.
Migliori GB; MDR-TB Division, Damien Foundation, Brussels, Belgium.

Eur Respir J ; 50(1)2017 07.

Article in En | MEDLINE | ID: mdl-28679614

Subject(s)

Antitubercular Agents/therapeutic use; Communicable Disease Control/standards; Extensively Drug-Resistant Tuberculosis/drug therapy; Infectious Disease Medicine/standards; Tuberculosis, Multidrug-Resistant/drug therapy; Aminosalicylic Acid/administration & dosage; Carbapenems/administration & dosage; Clofazimine/administration & dosage; Diarylquinolines/administration & dosage; Humans; Isoniazid/administration & dosage; Linezolid/administration & dosage; Mycobacterium tuberculosis; Treatment Outcome; World Health Organization

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Communicable Disease Control / Tuberculosis, Multidrug-Resistant / Extensively Drug-Resistant Tuberculosis / Infectious Disease Medicine / Antitubercular Agents Limits: Humans Language: En Journal: Eur Respir J Year: 2017 Type: Article Affiliation country: Spain

Fulltext

XML

PubMed Links

Search on Google